Immediate Impact
28 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Recent progress of CDK4/6 inhibitors’ current practice in breast cancer
2024 Standout
Works of Luigi Cerbone being referenced
Association of cabozantinib pharmacokinetics, progression and toxicity in metastatic renal cell carcinoma patients: results from a pharmacokinetics/pharmacodynamics study
2021
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Luigi Cerbone | 209 | 116 | 102 | 39 | 290 | |
| Susan E. Jorge | 199 | 136 | 112 | 22 | 298 | |
| Umair Majeed | 151 | 141 | 89 | 26 | 274 | |
| Guilherme Harada | 150 | 146 | 86 | 40 | 295 | |
| Leonardo Rojas | 145 | 141 | 70 | 35 | 255 | |
| Tristan Maurina | 152 | 107 | 118 | 29 | 289 | |
| Danilo Galizia | 102 | 165 | 55 | 30 | 261 | |
| Francesca Valcamonico | 120 | 126 | 87 | 43 | 309 | |
| Xian Zhang | 175 | 117 | 108 | 33 | 312 | |
| Huafei Chen | 202 | 169 | 99 | 35 | 310 | |
| Letizia Laera | 173 | 117 | 99 | 32 | 317 |
All Works
Login with ORCID to disown or claim papers
Loading papers...